Lanka Hospitals Corp. Plc

  • Market Cap: Mid Cap
  • Industry: Hospital
  • ISIN: LK0318N00002
LKR
106.50
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Lanka Hospitals Corp. Plc stock-summary
stock-summary
Lanka Hospitals Corp. Plc
Hospital
The Lanka Hospitals Corporation PLC is a tertiary care hospital in Sri Lanka, which is engaged in providing healthcare solutions. The Company's principal activity is to provide healthcare and laboratory services. It specializes in a range of procedures from conventional to minimally invasive surgeries. The Company offers various medical services, including emergency services, heart center, renal care, hemato-oncology, fertility center, kidney care center, vaccinations, surgical department, radiology services, eye clinic, mother and baby care, dental clinic, physiotherapy, dermatology, gastroenterology and neurosciences, among others. The Company, through its diagnostic laboratory, Lanka Hospitals Diagnostics (LHD), offers a range of diagnostic facilities, including fields, such as hematology, histopathology, chemical pathology, microbiology, molecular diagnostics, cytogenetics and flow cytometry. The Company's subsidiary is Lanka Hospitals Diagnostics (Private) Limited.
Company Coordinates stock-summary
Company Details
No.578, Elvitigala Mawatha, Narahenpita, Colombo 05 COLOMBO None : 05
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Bandula Wijesiriwardhana
Chairman of the Board
Gotabaya Rajapaksa
Director
Mr. Ashish Bhatia
Non-Executive Non-Independent Director
Adambarage De Alwis
Non-Independent Non-Executive Director
Mr. Chandima Jayasuriya
Non-Executive Director
P. Lionel
Non-Independent Non-Executive Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
3,372 Million
(Quarterly Results - Dec 2024)
Net Profit:
566 Million
stock-summary
Industry

Hospital

stock-summary
Market cap

LKR 24,107 Million (Mid Cap)

stock-summary
P/E

13.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.09%

stock-summary
Debt Equity

-0.64

stock-summary
Return on Equity

11.75%

stock-summary
Price to Book

1.60